iShares Neuroscience and Healthcare ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.47
資產淨值: 633.94
成立日期: 24/08/2022
 
分析
市值分佈:
55.81%
大市值
21.03%
中市值
13.81%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 61  
0%
 
100%
     10大 (43.10%)
代號 名稱 佔比% ▼ 持有日期
CAPRCapricor Therapeutics0.5030/10/2026
BNTCBenitec Biopharma0.4730/10/2026
CLPTClearPoint Neuro0.4730/10/2026
ABEOAbeona Therapeutics0.3630/10/2026
KYTXKyverna Therapeutics0.3530/10/2026
VNDAVanda Pharmaceuticals0.3530/10/2026
NWPHFNewron Pharmaceuticals SPA0.3130/10/2026
PEPGPepGen0.2430/10/2026
MOBIMobia Medical, Inc.0.2230/10/2026
CAMPCamp4 Therapeutics Corp0.2130/09/2026
ALECAlector0.2030/10/2026
ABOSAcumen Pharmaceuticals0.2030/09/2026
NGENNervGen Pharma Corp.0.1730/10/2026
NERVMinerva Neurosciences0.1530/10/2026
LRMRLarimar Therapeutics0.1330/10/2026
TRDAEntrada Therapeutics0.1230/10/2026
CGTXCognition Therapeutics0.1130/10/2026
AVXLAnavex Life Sciences Corp0.1030/10/2026
VYGRVoyager Therapeutics0.0930/10/2026
TNXPTonix Pharmaceuticals Holding Corp0.0930/10/2026
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.